Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jul;153(1):109-19.
doi: 10.1016/s0002-9440(10)65551-4.

Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development

Affiliations

Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development

S Matsumoto et al. Am J Pathol. 1998 Jul.

Abstract

Degradation of extracellular matrix (ECM) proteins in the aorta is a critical step for the development of atherosclerosis. Expression of matrix metalloproteinase (MMP)-12 (macrophage elastase), an elastin-degrading proteinase in the MMP family, was investigated in the thoracic aorta of rabbits fed a 1% cholesterol-containing diet for 16 weeks. In the atherosclerotic lesions, MMP-12 was produced abundantly at both the mRNA and protein levels, whereas no expression was observed in the normal rabbit aortas. The principal source of MMP-12 was macrophage foam cells (MFCs) that had infiltrated the atherosclerotic intima; this was demonstrated in both in vitro culture studies of MFCs purified from atherosclerotic lesions and immunohistochemical studies of aortic lesions. Additional biochemical studies using recombinant rabbit MMP-12 revealed that MMP-12 digested elastin, type IV collagen, and fibronectin and also activated MMP-2 and MMP-3. Expression of MMP-12 by human macrophage cell lines was increased by stimulation with acetylated low-density lipoprotein, implying augmentation of MMP-12 production during foam cell formation. Increased expression of MMP-12 in atherosclerotic lesions, concomitant with foam cell generation, which triggers the acceleration of ECM breakdown, is likely to be a critical step in the initiation and progression of the atherosclerotic cascade.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Northern blot analysis of MMPs in aortas of normal and cholesterol-fed rabbits. Total RNA was isolated from the whole aorta of a cholesterol-fed rabbit (lane 1), atherosclerotic intima of a cholesterol-fed rabbit (lanes 2 and 3), and the whole aorta of normal rabbits (lanes 4 and 5). Total RNA (30 μg each) was blotted on a nylon membrane, and full-length cDNA fragments of rabbit MMP-1, -2, -3, -9, and -12 and human glyceraldehyde 3-phosphate dehydrogenase (G3PDH) were used as probes. The hybridized membranes were exposed to x-ray films for 1 day (a and d), 3 days (c, e, and f), or 5 hours (b). This is a representative result of three independent experiments.
Figure 2.
Figure 2.
A schematic illustration of rabbit MMP-12. The latent form of rabbit MMP-12 (top), the active form of MMP-12 (middle), and the E. coli-expressed catalytic domain of MMP-12 (bottom) are illustrated. The meshed box in pro-MMP-12 indicates the signal peptides. In the structure of MMP-12cat, MAS represents starting amino acids Met, Ala, and Ser added at the amino terminus to be expressed in E. coli. The arrow shows the 19-kd MMP-12cat, which was obtained by purification. In the amino-terminal amino acid sequence of the 19-kd MMP-12cat, Met, Ala, Ser, and Phe were cleaved and the enzymes were started with Lys.
Figure 3.
Figure 3.
MMP-12 expression by cells from aorta with atherosclerotic intima. The conditioned medium of dissociated cells from a cholesterol-fed rabbit’s whole aorta without raised intima (lane 1) and with raised intima (lane 2) and cells from the whole aorta of a normal rabbit (lane 3) were subjected to Western blot analysis with an anti-MMP-12 polyclonal Ab. Also analyzed was the conditioned medium of purified MFCs from the intima of an atherosclerotic aorta (lane 7). Rabbit pro-MMP-12 expressed by COS-7 cells (lane 4), active MMP-12 (lane 5), which was trypsin-treated conditioned medium of MMP-12-expressed COS-7 cells, conditioned medium of vector-transfected COS-7 cells (lane 6), and medium incubated without cells (lane 8) were used as control samples. This is a representative result of three independent experiments.
Figure 4.
Figure 4.
Immunohistochemical localization of MMP-12. Serial sections of cholesterol-fed rabbit aorta were stained with hematoxylin and eosin (a) and immunostained with anti-rabbit macrophage MAb RAM-11 (b), anti-muscle actin MAb HHF-35 (c), and anti-rabbit MMP-12 polyclonal Ab (d). The sections indicate that most of the RAM-11-positive MFCs are stained with anti-MMP-12 Ab. Counterstaining with hematoxylin (b to d); original magnification, ×200.
Figure 5.
Figure 5.
Cellular localization of MMP-12 in superficial region of the intima. Serial sections were immunostained by anti-MMP-12 Ab (a), anti-macrophage Ab RAM-11 (b), and anti-muscle actin Ab HHF-35 (c). In addition to RAM-11-positive MFCs, HHF-35-positive SMCs are variably stained with anti-MMP-12 Ab. Counterstaining was with hematoxylin. Double immunostaining was performed for MMP-12 and the RAM-11 (d). MMP-12-positive macrophages are stained red-blue (thick arrows), whereas MMP-12-positive SMCs are stained red only (thin arrows). Note also double-negative cells (MMP-12-negative SMCs, arrowheads). Original magnification, ×400 (a to c) and ×1000 (d).
Figure 6.
Figure 6.
E. coli expression of catalytic domain of MMP-12. a: Purification of MMP-12cat, analyzed by SDS-PAGE and silver staining. Lane 1, whole E. coli extract; lane 2, MMP-12cat refolded from the inclusion body; lane 3, MMP-12cat purified on a heparin-Sepharose column. The arrows indicate two sizes, 20.5 and 19 kd, of MMP-12cat. b: Elastin zymography of MMP-12cat, with 0.1, 0.2, 0.5, and 1 μg of purified MMP-12cat applied to κ-elastin containing 10% SDS-PAGE gel. Elastin zymography was carried out by incubating the gel at 37°C for 72 hours.
Figure 7.
Figure 7.
Degradation of ECM proteins by MMP-12cat. Type I (lanes 1 and 2), type II (lanes 3 and 4), type III (lanes 5 and 6), type IV (lanes 7 and 8), and type V (lanes 9 and 10) collagens and fibronectin (lanes 11 and 12) were incubated with MMP-12cat (lanes 1, 3, 5, 7, 9, and 11) or alone (lanes 2 , 4, 6, 8, 10, and 12). The reaction products were analyzed by SDS-PAGE under reducing conditions and silver stained.
Figure 8.
Figure 8.
Time- and concentration-dependent pro-MMP-2 and -3 activation by MMP-12cat. a: Activation of pro-MMP-2 by MMP-12cat. Five microliters of conditioned medium of rabbit MMP-2-expressing COS-7 cells was reacted with 10 or 1 μg/ml MMP-12cat in reaction buffer (2 μmol/L pepstatin A, 2 mg/ml Pefabloc, and 1 μg/ml leupeptin in buffer A). The reactions were quenched at 0, 0.5, 1, 2, 4, or 6 hours with EDTA at a final concentration of 50 mmol/L. The reaction products were analyzed by Western blot using an anti-human MMP-2 MAb. The pro-MMP-2 (72 kd) and active MMP-2 (62 kd) are indicated by arrows. b: Activation of pro-MMP-3 by MMP-12cat. Conditioned medium of COS-7 cells containing rabbit MMP-3 was reacted with MMP-12cat, and an anti-rabbit MMP-3 MAb, MP1807, was used for Western blot analysis. The pro-MMP-3 (58 kd) and active MMP-3 (46 kd) are indicated. This is a representative experiment of two performed.
Figure 9.
Figure 9.
MMP-12 expression is enhanced by stimulation with AcLDL. a: Northern blot analysis of MMP-12 expression by macrophage-differentiated THP-1 (lanes 1 to 3) and U937 (lanes 4 to 6) cells under stimulation with AcLDL (lanes 2 and 5) or GM-CSF (lanes 3 and 6). Radiolabeled human MMP-12 cDNA (top) and human β-actin cDNA (bottom) were used as probe DNAs. This is a representative experiment of three performed. b: The relative amounts of mRNA for MMP-12 were standardized with the amount of mRNA for β-actin and are indicated as 1 for the amount of MMP-12 in each cell line under normal conditions. The values are the mean ± SD of triplicate cultures.

References

    1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809 - PubMed
    1. Watanabe T, Tokunaga O, Fan J, Shimokama T: Atherosclerosis and macrophages. Acta Pathol Jpn 1989, 39:473-486 - PubMed
    1. Dollery CM, McEwan JR, Henney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 77:863-868 - PubMed
    1. Holvoet P, Collen D: Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994, 8:1279-1284 - PubMed
    1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924 - PubMed

Publication types

MeSH terms